Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullish ↗
Hospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing medicine prices by 70%. Jefferies and Emkay expect manageable earnings impacts, despite near-term margin pressures. Jefferies favours Fortis, Manipal, Apollo, Max Healthcare and Medanta, citing strong demand and attractive valuations.
2 sources
- The Economic Times Stocks · 9 Oct, 11:14 IST
- The Economic Times Markets · 9 Oct, 11:14 IST
Open on desktop to take part.
0 comments
Comments are posted by users and are not reviewed by Bazaar Updates.
Open on desktop to take part.
Sign in to comment.
No comments yet.